3
Views
1
CrossRef citations to date
0
Altmetric
Original Article

Evaluation of a new chromogenic substrate assay for the measurement of the prothrombin time

Pages 563-568 | Received 04 Dec 1992, Accepted 02 Apr 1993, Published online: 28 Aug 2009
 

Abstract

van Wersch J. W. J. Evaluation of a new chromogenic substrate assay for the measurement of the prothrombin time. Scand J Clin Lab Invest 1993; 53: 563-568.

The chromogenic prothrombin time assay Nycotest ChromR was evaluated and compared with another chromogenic assay (ChromoquickR) and with the well-known coagulometric ThrombotestR. The intra-assay variation of the test was satisfying both in the normal range (CV = 3.6%) and in the therapeutical range of oral anticoagulation (CV = 3.5%). These values were somewhat higher than those of the ChromoquickR test (1.3% and 1.1%) and those of the ThrombotestR (2.3% and 2.5%). The inter-assay variation coefficient amounted to 3.3% in the normal range and in the therapeutical oral anticoagulation range to 4.4%. The respective values for the ChromoquickR test were somewhat lower (2.2% and 3.9%), those of the ThrombotestR in the normal range were also lower (2.1%), and in the therapeutical range they were much higher (9.2%). The coefficients of correlation of the Nycotest ChromR test in the therapeutical range were highest when comparing them with those for the ChromoquickR test (r = 0.97; p < 0.0001) and somewhat lower in comparison with the ThrombotestR (r = 0.95; p < 0.0001). The results of the three methods paralleled also in the starting phase of oral anticoagulation treatment. Storage at 4°C and at 25°C showed good stability of the Nycotest ChromR reagent for up to 24 h.

We conclude that the Nycotest ChromR assay is well suited for the measurement with a centrifugal fast analyser, which is attractive on behalf of the usually large series of requests for prothrombin time measurements when monitoring oral anticoagulation therapy. It showed a good performance and with other tests a comparable performance, but the simultaneous use of the studied tests cannot be recommended.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.